FMC (NYSE:FMC) on Wednesday was downgraded to Sector Perform from a previous investment rating of Outperform by analysts at ...

In a report released yesterday, Daniel Perlin from RBC Capital maintained a Hold rating on DXC Technology (DXC – Research Report), with a price ...

RBC Capital analyst Kenneth Herbert maintained a Buy rating on Transdigm Group (TDG – Research Report) yesterday and set a price target of ...

RBC Capital Markets adjusted its price target for Regeneron Pharmaceuticals (NASDAQ:REGN), reducing it to $1,045 from the previous target of $1,059. Despite the decrease, the firm maintained its ...

RBC Capital analysts confirmed their positive stance on Alphabet Inc. (NASDAQ:GOOGL) shares, maintaining an Outperform rating ...

Find insight on TotalEnergies, oil and natural gas futures, and more in the latest Market Talks covering Energy and Utilities ...

J.M. Smucker Co. chief executive Mark Smucker leaned on close advisers when he made the decision to bolster the jelly and ...

RBC Capital Markets head of global energy research Greg Pardy has made two changes to his Global Energy Best Ideas list, ...

RBC Capital Mkts has recently raised SAGE Therapeutics Inc (SAGE) stock to Sector Perform rating, as announced on November 21, 2024, according to Finviz. Earlier, on October 10, 2 ...

Find insight on BNP Paribas, UBS, Kasikornbank and more in the latest Market Talks covering Financial Services.

Neumora Therapeutics Inc (NMRA) stock saw a modest uptick, ending the day at $1.91 which represents a slight increase of $0.05 or 2.69% from the prior close of $1.86. The stock opened at $1.87 and ...